Astellas reports IZERVAY reduced driving eligibility loss risk in eye disease study May 12, 2026 09:04AM
Jefferies Upgrades Astellas Pharma Inc (4503:JP) (ALPMY) to Buy Mar 23, 2026 04:29AM
Astellas Pharma Inc (4503:JP) (ALPMY) PT Raised to JPY2,200 at Bernstein SocGen Group Mar 12, 2026 08:24AM
PADCEV plus Keytruda reduces bladder cancer recurrence risk by 47% Feb 27, 2026 10:04AM
UBS Starts Astellas Pharma Inc (4503:JP) (ALPMY) at Neutral Jan 26, 2026 05:30AM


Sep 2, 2025 06:00AM Bernstein SocGen Group Downgrades Astellas Pharma Inc (4503:JP) (ALPMY) to Market Perform
Feb 10, 2025 05:01PM Pfizer (PFE) and Astellas PADCEV plus KEYTRUDA Shows Long-Term Efficacy in First-Line Treatment of la/mUC
Jul 18, 2024 05:20AM Jefferies Downgrades Astellas Pharma Inc (4503:JP) (ALPMY) to Hold